Nadravaleucel

**Semantic type:** Cell|Pharmacologic Substance

**Definition:** A preparation of allogeneic, nicotinamide (NAM)-expanded natural killer (NK) cells, with potential cytolytic and antineoplastic activities. Upon administration, nadravaleucel may lyse cancer cells. These cells also secrete pro-inflammatory cytokines, which further stimulate an anti-tumor immune response. Ex-vivo treatment with the vitamin B3 derivative NAM increases the in-vivo homing, retention and proliferation potential of the NK cells.

**Synonyms:** - Allogeneic NAM-expanded NK Cells GDA-201 - Allogeneic Nicotinamide-expanded Natural Killer Cells GDA-201 - GDA 201 - GDA-201 - GDA201 - NADRAVALEUCEL - NAM NKs GDA-201 - NAM-expanded Allogeneic NK Cells GDA-201